Roxadustat in the Treatment of Pure Red Cell Aplasia Associated With Anti-EPO Antibodies
{{output}}
Erythropoiesis-stimulating agents (ESAs) are essential in managing anemia associated with chronic kidney disease (CKD). Although iron deficiency and inflammation are the most frequent causes of ESA hyporesponsiveness, a rare but serious complication is pure re... ...
